Analysis of risk factors for low bone mineral density in inflammatory bowel disease

Digestion

Volumn 73, Issue 1, 2006, Pages 40-46

  Frei, Pascal ^a   Fried, Michael ^a   Hungerbühler, Vera ^a   Rammert, Christina ^a   Rousson, Valentin ^b   Kullak Ublick, Gerd A ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Crohn's disease; Dual energy X ray absorptiometry, bone mineral density measurement; Osteopenia; Osteoporosis; Risk factors, low bone mineral density; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; METHOTREXATE; PREDNISONE; STEROID;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; CONTROLLED STUDY; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; INTESTINE RESECTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; OSTEOPENIA; OSTEOPOROSIS; PATHOLOGY; PATIENT MONITORING; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SCORING SYSTEM; STEROID THERAPY; SWITZERLAND; ULCERATIVE COLITIS; WORLD HEALTH ORGANIZATION;

EID: 33744486338     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092013     Document Type: Article

References (44)

1. Ardizzone S, Bollani S, Bettica P, Bevilacqua M, Molteni P, Bianchi Porro G: Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis. J Intern Med 2000;247:63-70.
2. Dear KL, Compston JE, Hunter JO: Treatments for Crohn's disease that minimise steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 2001;20:541-546.
3. Silvennoinen JA, Lehtola JK, Niemela SE: Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996;31:367-371.
4. Schulte C, Goebell H, Roher HD, Schulte KM: Genetic determinants of IL-6 expression levels do not influence bone loss in inflammatory bowel disease. Dig Dis Sci 2001;46:2521-2528.
5. Staun M, Tjellesen L, Thale M, Schaadt O, Jarnum S: Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-232.
6. Ghosh S, Cowen S, Hannan WJ, Ferguson A: Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-1039.
7. Szathmari M, Pronai L, Tulassay Z: Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol 1998;93:848-849.
8. Reffitt DM, Meenan J, Sanderson JD, Jugdaohsingh R, Powell JJ, Thompson RP: Bone density improves with disease remission in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2003;15:1267-1273.
9. Cino M, Greenberg GR: Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy. Am J Gastroenterol 2002;97:915-921.
10. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH: Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002;8:87-92.
11. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, Compston JE: A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23:95-104.
12. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK: A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-76.
13. Schulte C, Dignass AU, Mann K, Goebell H: Bone loss in patients with inflammatory bowel disease is less than expected: a follow-up study. Scand J Gastroenterol 1999;34:696-702.
14. von Tirpitz C, Steder-Neukamm U, Glas K, Sander S, Ring C, Klaus J, Reinshagen M: Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association. Z Gastroenterol 2003;41:1145-1150.
15. von Tirpitz C, Epp S, Klaus J, Mason R, Hawa G, Brinskelle-Schmal N, Hofbauer LC, Adler G, Kratzer W, Reinshagen M: Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. Eur J Gastroenterol Hepatol 2003;15:1165-1170.
16. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, Amor B, Couturier D: Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporos Int 1995;5:156-160.
17. Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, Naccarato R, Martin A: Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292-1297.
18. de Jong DJ, Corstens FH, Mannaerts L, van Rossum LG, Naber AH: Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 2002;97:2011-2015.
19. de Jong DJ, Mannaerts L, van Rossum LG, Corstens FH, Naber AH: Longitudinal study of bone mineral density in patients with Crohn's disease. Dig Dis Sci 2003;48:1355-1359.
20. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE: Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988;29:1332-1336.
21. Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM: Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000;119:909-920.
22. Bernstein CN, Blanchard JF, Leslie W, Wajda A, Yu BN: The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann Intern Med 2000;133:795-799.
23. van Staa TP, Cooper C, Brusse LS, Leufkens H, Javaid MK, Arden NK: Inflammatory bowel disease and the risk of fracture. Gastroenterology 2003;125:1591-1597.
24. Beltinger J, Froehlich F: Patients with inflammatory bowel disease in specialist gastroenterology practice: a prospective survey. Schweiz Rundsch Med Prax 2005;94:459-465.
25. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C: Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-233.
26. Bernstein CN: Limiting fracture risk in Crohn's disease: is there anything better than calcium and vitamin D? Clin Gastroenterol Hepatol 2005;3:110-112.
27. Bartram SA, Peaston RT, Rawlings DJ, Francis RM, Thompson NP: A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn's disease. Aliment Pharmacol Ther 2003;18:1121-1127.
28. Siffledeen JS, Fedorak RN, Siminoski K, Jen H, Vaudan E, Abraham N, Steinhart H, Greenberg G: Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn's disease. Clin Gastroenterol Hepatol 2005;3:122-132.
29. Haderslev KV, Tjellesen L, Sorensen HA, Staun M: Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterology 2000;119:639-646.
30. von Tirpitz C, Klaus J, Steinkamp M, Hofbauer LC, Kratzer W, Mason R, Boehm BO, Adler G, Reinshagen M: Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate. Aliment Pharmacol Ther 2003;17:807-816.
31. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F: Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-256.
32. Schoon EJ, van Nunen AB, Wouters RS, Stockbrugger RW, Russel MG: Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. Scand J Gastroenterol Suppl 2000;232:43-47.
33. Reed CA, Nichols DL, Bonnick SL, DiMarco NM: Bone mineral density and dietary intake in patients with Crohn's disease. J Clin Densitom 1998;1:33-40.
34. Homik J, Suarez-Almazor ME, Shea B, Cranney A, Wells G, Tugwell P: Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000:CD000952.
35. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J: Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-415.
36. Jahnsen J, Falch JA, Aadland E, Mowinckel P: Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-319.
37. Hela S, Nihel M, Faten L, Monia F, Jalel B, Azza F, Slaheddine S: Osteoporosis and Crohn's disease. Joint Bone Spine 2005;72:403-407.
38. Jahnsen J, Falch JA, Mowinckel P, Aadland E: Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study. Scand J Gastroenterol 2004;39:145-153.
39. Mazlam MZ, Hodgson HJ: Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773-778.
40. MacDonald BR, Gowen M: Cytokines and bone. Br J Rheumatol 1992;31:149-155.
41. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P: Interleukin-1 beta stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 1991;10:15-21.
42. Stockbrugger RW, Schoon EJ, Bollani S, Mills PR, Israeli E, Landgraf L, Felsenberg D, Ljunghall S, Nygard G, Persson T, Graffner H, Bianchi Porro G, Ferguson A: Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease. Aliment Pharmacol Ther 2002;16:1519-1527.
43. Jahnsen J, Falch JA, Mowinckel P, Aadland E: Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol 2002;37:192-199.
44. Schoon EJ, Muller MC, Vermeer C, Schurgers LJ, Brummer RJ, Stockbrugger RW: Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis in Crohn's disease? Gut 2001;48:473-477.